Shopping cart ITEMS
 modern scholarly publishers in the finest tradition
Login Register
Home
Books
Journals
References
A-Z Index
Author Index
For Our Authors
User Area
Shopping Cart
Contact
Electronic Data Center

Journal of Long-Term Effects of Medical Implants

 

ISSN for PRINT: 1050-6934

Institutional price:

$1021.00

Issues per year:

6

For Online Access

Best Paper Award Selection - Editorial Board Site

Add subscription to shopping cart

2006, Volume16

Issue 6

  82 pages  

   

click 'Save as...' here to save XML metadata

Issue price - $189.00  

Add to shopping cart

  • Surfactant Induced Glistenings: Surface Active Ingredients in Ophthalmic Solutions May Enhance Water Entry into the Voids of Implanted Acrylic Intraocular Lenses
  • Masahiko Ayaki
    Department of Ophthalmology, Fujigaoka Hospital, Showa University School of Medicine, Japan

    Hitoshi Nishihara
    Department of Ophthalmology, Fujigaoka Hospital, Showa University School of Medicine, Japan

    Shigeo Yaguchi
    Department of Ophthalmology, Fujigaoka Hospital, Showa University School of Medicine, Japan

    Ryohei Koide
    Department of Ophthalmology, Showa University School of Medicine, Japan


    ABSTRACT

    Purpose: To investigate the light scattering properties of acrylic intraocular lenses (IOLs) placed in eyes treated with diclofenac sodium (Diclod®, Wakamoto, Japan) and betamethasone phosphate (Rinderon®, Shionogi, Japan) ophthalmic solutions. Methods: The light scattering properties of IOLs (MA30BA, Alcon laboratories) placed in 32 eyes treated with Diclod® and 31 treated with Rinderon® were evaluated 3 years after implantation using Scheimpflug photography. Results: The averaged intensity of glistenings was 9.0 CCT (computer compatible tapes) in the Diclod® test group and 4.2 CCT in the Rinderon® test group (p = 0.002). The intensity of surface light scattering for the Diclod® and Rinderon® test groups was 24.0 CCT and 26.9 CCT, respectively (p = 0.081). Conclusion: The Diclod® test group had a greater number of glistenings than the Rinderon® test group. Both drugs have similar anti-inflammatory properties and Diclod®, unlike Rinderon®, also contains the surfactant polysorbate. We proposed that the presence of surfactant, or other ingredient, in commercially available eyedrops may enhance the development of glistenings.

    Download article, 451-457 pages

    Article price - $35.00  

    Add to shopping cart

    << Previous article   Next article >>

    Designed by offsiteteam Designed by offsiteteam Designed by offsiteteam
    Begell House Inc.
    50 Cross Highway,
    Redding, CT 06896
    TEL (203) 938 1300
    FAX (203) 938 1304
    orders@begellhouse.com